Radius Health Business Update
April 22, 2021 08:15 ET
|
Radius Health Inc.
Growth of 14% for new U.S. TYMLOS® patients in Q1, 2021 vs. Q4, 2020Q1, 2021 TYMLOS net revenue impacted by seasonality and distribution channel destockingApril, 2021 month-to-date new patient adds...
Radius Health to Announce First Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Friday, May 7, 2021
April 20, 2021 16:30 ET
|
Radius Health Inc.
BOSTON, April 20, 2021 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter financial results on Friday, May 7, 2021. The Company will host a...
Radius Health Provides Update on Abaloparatide
March 24, 2021 08:00 ET
|
Radius Health Inc.
Regulatory success achieved in Japan by partner Teijin Pharma LimitedOstabaro® approved for treatment of male & female OP patients at high risk of fractureJapan is currently the largest anabolic...
Radius Health, Inc. Announces $175 Million Financing Transaction
March 03, 2021 16:15 ET
|
Radius Health Inc.
Repurchases $112.2 million of principal amount of the 3.00% convertible notes due September 1, 2024 (“2024 Notes”), representing approximately 37% of the outstanding 2024 NotesEstimated excess cash...
Radius Health, Inc.: Fourth Quarter and Full Year Results
February 25, 2021 07:00 ET
|
Radius Health Inc.
Full year 2020 TYMLOS® U.S. net sales of $208 million was year-over-year growth of 20%Q4 2020 TYMLOS U.S. net sales: $60 million was 8% growth vs. Q4 2019 and 19% growth vs. Q3 2020New patient starts:...
Radius Health to Present at 10th Annual SVB Leerink Global Healthcare Conference
February 17, 2021 08:30 ET
|
Radius Health Inc.
BOSTON, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that it will provide a corporate update at the 10th Annual SVB Leerink Global Healthcare Conference at...
Radius Health to Announce Fourth Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, February 25, 2021
February 16, 2021 08:30 ET
|
Radius Health Inc.
BOSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter financial results on Thursday, February 25, 2021. The Company will host...
Radius Health, Inc. Provides Abaloparatide Business Update
February 12, 2021 12:33 ET
|
Radius Health Inc.
17% growth in January 2021 for new TYMLOS® patients vs. previous 4 month trailing averageHistomorphometry study published: Journal of Bone & Mineral Research in January 2021Cardiovascular safety...
Radius Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 06, 2021 12:00 ET
|
Radius Health Inc.
BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Kelly Martin, President and CEO will present a virtual corporate update at the 39th Annual J.P....
Radius Health, Inc. Announces Acquisition of Orphan Disease Program
January 06, 2021 06:00 ET
|
Radius Health Inc.
RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseasesPrader-Willi syndrome (“PWS”) will be the initial...